ESC Premium Access

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.

Congress Presentation

About the speaker

Doctor Lorenzo Martin Lobo

Campo de Mayo Military Hospital, Buenos Aires (Argentina)
0 follower

4 more presentations in this session

Mechanistic insights into HDL cholesterol - Current insights.

Speaker: Professor A. Tybjaerg-Hansen (Copenhagen, DK)


Elevated HDL-C is associated with adverse cardiovascular outcomes

Speaker: Doctor M. Allard-Ratick (Atlanta, US)


Serum modified high density lipoprotein levels assessed by a novel assay was associated with coronary artery calcification in an apparently healthy population

Speaker: Professor T. Okamura (Tokyo, JP)


Next steps in addressing HDL cholesterol clinical practice.

Speaker: Professor A. Catapano (Milan, IT)


Access the full session

HDL cholesterol - A moving target

Speakers: Doctor L. Lobo, Professor A. Tybjaerg-Hansen, Doctor M. Allard-Ratick, Professor T. Okamura, Professor A. Catapano

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb